DSGN
Design Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Design Therapeutics (DSGN) Stock: Buy, Sell, or Hold?
$10.65
-0.15 (-1.39%)
▼
5d:
+3.0%
30d:
-2.38%
90d:
-27.35%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (90%)
Quality Score
54/100
Position
FAIR
30-Day Fair Range
$10.08 – $11.50
Position: FAIR
Forward P/E & Valuation
-6.9x
Next 12M consensus est.
Wall Street Target
$21.57
+102.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.62 / $11.43
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: DSGN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When DSGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: DSGN is currently trading at $10.65, which is considered fair relative to its 30-day fair value range of $10.08 to $11.50.
Technical Outlook: Technically, DSGN is in a strong downtrend. Immediate support is located at $9.62, while resistance sits at $11.43.
Market Sentiment: DSGN scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.57 (+102.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DSGN is in a strong downtrend. Immediate support is located at $9.62, while resistance sits at $11.43.
Market Sentiment: DSGN scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.57 (+102.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.08 -
$11.50
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.6%
Trading Range & Key Levels
30-Day Trading Range
$10.08 -
$11.50
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$1.21
(11.4%)
Support Level
$9.62
Resistance Level
$11.43
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 102.5% below Wall St target ($21.57)
- BULLISH: Bottoming setup score 68/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-6.85
Wall Street Target
$21.57
(+102.5%)
Share DSGN Analysis
Share this live DSGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 10, 2026 11:58 PM ET
Data refreshes hourly during market hours. Next update: 12:58 AM
Data refreshes hourly during market hours. Next update: 12:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DSGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 55 HOLD |
|
RZLT
Rezolute Inc |
STRONG BUY
11 analysts |
$10 | 72 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DSGN Research Pages
